Table 1 Baseline and clinical characteristics of the study population stratified according to diabetes status
| Â | Total | DM | Non-DM | P-value |
|---|---|---|---|---|
No. of CEAs | 675 | 265 (39.3) | 410 (60.7) | Â |
Mean age (years) | 68.5 ± 7.7 | 68.1 ± 7.3 | 68.8 ± 7.9 | 0.222 |
Male sex | 590 (87.4) | 228 (86.0) | 362 (88.3) | 0.389 |
BMI (kg/m2) | 24.1 ± 2.9 | 24.2 ± 3.0 | 24.0 ± 2.8 | 0.669 |
Diabetes duration (years) | NA | 11.3 ± 9.8 | NA | NA |
Hypoglycemic medications | ||||
 Insulina | NA | 47 (17.7) | NA | NA |
 Metformina | NA | 185 (69.8) | NA | NA |
Risk factor | ||||
 Smoking | 450 (66.7) | 182 (68.7) | 268 (65.4) | 0.373 |
 Hypertension | 513 (76.0) | 216 (81.5) | 297 (72.4) | 0.007 |
 Dyslipidemiab | 466 (69.0) | 192 (72.5) | 274 (66.8) | 0.123 |
Comorbidities | ||||
 CAD | 131 (19.4) | 72 (27.2) | 59 (14.4) | < 0.001 |
 Subclinical CAD | 23 (3.3) | 10 (3.8) | 13 (3.2) | 0.673 |
 CKD | 112 (16.6) | 59 (22.3) | 53 (12.9) | 0.001 |
 PAOD | 45 (6.7) | 27 (10.2) | 18 (4.4) | 0.003 |
Carotid stenosis | ||||
 Degree of stenosis (%) | 76.2 ± 9.5 | 76.0 ± 8.6 | 76.3 ± 10.0 | 0.705 |
 SCSO | 72 (10.7) | 29 (10.9) | 43 (10.5) | 0.851 |
 Symptomatic stenosis | 324 (48.0) | 116 (43.8) | 208 (50.7) | 0.077 |
CEA | ||||
 General anesthesia | 405 (60.0) | 155 (58.5) | 250 (61.0) | 0.520 |
 Use of shunt | 421 (62.4) | 168 (63.4) | 253 (61.7) | 0.658 |
 Reconstruction | 0.897 | |||
  Patch angioplasty | 653 (96.7) | 257 (97.0) | 396 (96.6) |  |
  Primary closure | 10 (1.5) | 3 (1.1) | 7 (1.7) |  |
  Others | 12 (1.8) | 5 (1.9) | 7 (1.7) |  |